Phase I clinical trial of SGX 94 in healthy volunteers.

Trial Profile

Phase I clinical trial of SGX 94 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Apr 2014

At a glance

  • Drugs Dusquetide (Primary)
  • Indications Mucositis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 09 Apr 2014 New trial record
    • 07 Apr 2014 SGX 94 showed safety in a completed phase I trial in healthy volunteers, according to a Soligenix media release.
    • 12 Dec 2012 Soligenix acquired all rights to SGX 94, including preclinical and phase I data in healthy human volunteers, from the University of British Columbia, Canada, according to a Soligenix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top